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Abstract
Background: ‘‘Cumulative meta-analysis’’ describes a statistical procedure to calculate, retrospectively, summary estimates
from the results of similar trials every time the results of a further trial in the series had become available. In the early 1990s,
comparisons of cumulative meta-analyses of treatments for myocardial infarction with advice promulgated through medical
textbooks showed that research had continued long after robust estimates of treatment effects had accumulated, and that
medical textbooks had overlooked strong, existing evidence from trials. Cumulative meta-analyses have subsequently been
used to assess what could have been known had new studies been informed by systematic reviews of relevant existing
evidence and how waste might have been reduced.
Methods and Findings:We used a systematic approach to identify and summarise the findings of cumulative meta-analyses
of studies of the effects of clinical interventions, published from 1992 to 2012. Searches were done of PubMed, MEDLINE,
EMBASE, the Cochrane Methodology Register and Science Citation Index. A total of 50 eligible reports were identified,
including more than 1,500 cumulative meta-analyses. A variety of themes are illustrated with specific examples. The studies
showed that initially positive results became null or negative in meta-analyses as more trials were done; that early null or
negative results were over-turned; that stable results (beneficial, harmful and neutral) would have been seen had a meta-
analysis been done before the new trial; and that additional trials had been much too small to resolve the remaining
uncertainties.
Conclusions: This large, unique collection of cumulative meta-analyses highlights how a review of the existing evidence
might have helped researchers, practitioners, patients and funders make more informed decisions and choices about new
trials over decades of research. This would have led to earlier uptake of effective interventions in practice, less exposure of
trial participants to less effective treatments, and reduced waste resulting from unjustified research.
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Introduction
In 1992, a team lead by Tom Chalmers and Fred Mosteller
introduced the term ‘cumulative meta-analysis’ to describe a
statistical procedure to calculate, retrospectively, summary esti-
mates based on the results of similar trials every time the results of
a further trial in the series had become available [1]. One of their
two papers published in 1992 made clear how important this
procedure was for auditing both research and healthcare advice.
Comparisons of the results of cumulative meta-analyses of
treatments for myocardial infarction with the advice that had
been promulgated through medical textbooks [2] made clear not
only that research had continued long after robust estimates of
treatment effects had accumulated, but also that medical textbooks
had overlooked strong, existing evidence from clinical trials, both
of beneficial and of lethal effects of treatments [3].
Cumulative meta-analyses have subsequently been used to
assess what could have been known had the design of new studies
been informed by reference to systematic reviews of relevant
existing evidence and how these might have reduced waste [4].
Cumulative meta-analyses emphasise the need for the design of
new studies to be informed by existing research [5] and for the
results of new studies to be set in the context of updated systematic
reviews of the relevant evidence from all sufficiently similar studies
[6]. The idea of using the accumulating evidence to make
decisions about the design and ongoing conduct of trials is not
new: the report of a case study published by Henderson and
colleagues nearly 20 years ago noted ‘‘Our thesis is that if related
published trials are available, a meta-analysis should be started in
the planning stages of a clinical trial, continued through the
ongoing conduct of the trial, and performed as one analysis among
many in the final analysis of the trial’’ [7]. Such reviews and meta-
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analyses help to provide the ethical, scientific and environmental
justification for both new study and for any future studies [8].
In this methodological review, we use systematic methods to
search for and summarise the findings of cumulative meta-analyses
of studies of the effects of clinical interventions, published from
1992 to 2012. We describe the different settings for these studies
and explore their findings in the context of unnecessary
duplication of effort or waste if trials were done after a robust
finding would have been found if a review and meta-analysis of
existing research had been performed. By conducting this research
as a systematic review, our aim is to provide the most
comprehensive collection of cumulative meta-analysis of studies
of healthcare interventions. The searching for this review also
identified several cumulative meta-analyses in other types of health
research, which are not summarised here but have been discussed
in brief elsewhere [4]. For example, if epidemiological studies
investigating possible aetiological factors in sudden infant death
syndrome had taken proper account of the accumulating evidence,
the lethal effect of ‘front lying’ would have been recognized at least
a decade earlier, and tens of thousands of infant deaths could have
been avoided [9]. A cumulative meta-analysis of 55 studies that
continued to be conducted over more than two decades showed
that for over 17 years there had been ample evidence that never-
smoking women who had been exposed to spousal smoking were
more likely than controls to develop lung cancer [10].
Methods
Inclusion criteria
Studies were eligible if they included a cumulative meta-analysis
of studies of the relative effects of alternative healthcare
interventions. Ideally, the cumulative meta-analysis would be
presented as a graph showing the summary estimates as each
study’s result was added to the meta-analyses in the order this had
been published or became available in some other way. However,
studies were eligible if these graphs or the separate summary
estimates were not available, but the general findings or
implications of the cumulative meta-analyses were reported.
Studies were eligible if a single cumulative meta-analysis was
presented, or if a meta-epidemiological project had been done in
which numerous systematic reviews or meta-analyses were
included. Eligible cumulative meta-analyses had sometimes been
done as part of the planning process for a new study to explore
how the evidence base had evolved. Studies were not included if
only surrogate outcome measures were used unless - like blood
pressure and severe anaemia, for example - these were unambig-
uously important. The searches also identified cumulative meta-
analysis in other types of health research (including observational
epidemiology and genetics) but these were not eligible for this
review.
Search strategy
We wished to identify published reports containing graphs of
cumulative meta-analyses. An initial search of Pubmed Clinical
Queries using the term ‘cumulative meta-analysis’ retrieved 822
records. The selected papers were screened by one author (IC),
who selected a set of 23 records which were added to a set of core
articles that had been previously identified as part of this author’s
general interest in this area. This full set of papers were then
analysed to obtain ideas for free-text search terms and index or
MeSH terms for use in a final search strategy.
Searches were then run on the following databases: MEDLINE,
OVID (1946–2012, In-Process and other non-indexed citations);
EMBASE, OVID (1947–2012); the Cochrane Methodology
Register (2012); and Science Citation Index (2012). No language
or publication date restrictions were applied. The following search
strategy was used for MEDLINE: cumulative adj10 meta?ana-
lys$.mp. OR (cumulative.mp. and meta-analysis.pt.). The search of
the Cochrane Methodology Register combined the output of a
simple search for the word ‘cumulative’ in the abstract with that
for a search for records that had been assigned the term ‘Meta-
analysis updating and cumulative meta-analysis’ by the compilers
of the Register. The searches were conducted in June 2012.
The reference lists of relevant systematic reviews and other
publications were checked to identify additional articles [11]. A
search was undertaken in Google Scholar to identify relevant
terms in the full text of articles where relevant concepts had not
been located in bibliographic databases using searches of titles,
abstracts and index terms.
Assessment of studies, data extraction and analysis
Records were exported from Endnote to Sente for first
screening by one of the authors (AB). This screening was
deliberately over-inclusive, and all potentially eligible articles or
unclear articles were checked by a second author (IC). The
eligibility of all studies arising from this process was then
confirmed by a third author (MC) before their inclusion in this
review.
The process of data extraction was piloted in ten records and
emerging themes identified. A final data extraction form was then
agreed. All eligible papers were read, and passages of text
commenting on the details of the cumulative meta-analysis and the
implications of the completed cumulative meta-analyses were
identified and extracted. This was done by one author (AB) and
the data extracted were checked against the original articles by the
other authors (IC and MC).
No attempts were made to combine the results of the included
studies, because the aim of this review is to present a range of
examples and identify themes across the cumulative meta-analyses
identified, rather than to attempt to generate a statistical finding.
Similarly, this review does not seek to estimate the incidence or
prevalence of trials that have been conducted unnecessarily, since
that would be done better with a comprehensive study of large
cohorts of trials addressing the same or similar questions. Instead,
it seeks to identify and report a range of examples to examine
whether cumulative meta-analyses might have led to different
choices in the conduct of new research.
Results
Results of the search
This initial screening identified 942 records needing inspection,
of which 818 were excluded in the initial screening. This screening
identified 46 records for inclusion and 78 needing further review.
The second screening step excluded 74 of these, leaving 50 reports,
including more than 1500 cumulative meta-analyses of clinical
intervention studies, as eligible.
Included studies
The included studies were published from 1992 to 2012
inclusive. Most of these studies focused on a single question for a
systematic review or meta-analysis, and included just one graphical
presentation of a cumulative meta-analysis. The 50 studies
addressed a wide range of health problems. Fourteen covered
aspects of surgery for a variety of problems (reducing infection and
bleeding and improving surgical technique). Eleven studies
concerned heart disease, and there were at least two for each of
stroke, neonatal problems, infectious disease, cancer, mental
Cumulative Meta-Analyses
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health, dental health and respiratory illness. There were single
studies in obstetrics, musculoskeletal disease, kidney disease and
gastrointestinal disease. The number of individual research studies
in each of the cumulative meta-analyses we identified ranged from
4 trials of continuous versus interrupted techniques for elective
midline abdominal fascial closure [12] to more than 60 trials for
aprotinin in cardiac surgery [13].
Nearly all of the cumulative meta-analyses had been conducted
as retrospective exercises to explore how the evidence base had
evolved. However, some were used to inform the design of a new
study. For example, Algra and van Gijn presented a cumulative
meta-analyses which was used to inform the need for the
European and Australian Stroke Prevention in Reversible
Ischaemia Trial (ESPRIT) [14].
A variety of themes were apparent from the cumulative meta-
analyses and these are illustrated here with specific examples. A
detailed explanation is not provided for each cumulative meta-
analyses, but the citations for all the included studies are available
in Appendix S1. The included studies showed that initially positive
results became null or negative in the meta-analysis as more trials
were done; that early null or negative results were over-turned;
that stable results (beneficial, harmful and neutral) would have
been seen had a meta-analysis of existing evidence been done
before the new trial; and that additional trials had been much too
small to resolve the remaining uncertainties.
Positive results becoming less so
Cumulative meta-analyses have shown how replications have
challenged initially favourable results [15–18] where the early
trials were favourable but not statistically significant. For example,
Klein and colleagues examined the effects of cognitive behavioural
therapy (CBT) for adolescent depression, using the publication
dates for 11 randomised trials to build a cumulative meta-analysis.
They found that the effect size from the meta-analyses had
decreased steadily from the large effects observed in the earliest
trials, with narrowing confidence intervals as the data accumulat-
ed. However, they also noted that the trend could be related to
methodological differences between the studies and wrote ‘‘these
differences appear to reflect both a shift from an initial emphasis
on demonstrating the efficacy of treatment in controlled research
settings to an emphasis on demonstrating the effectiveness of
treatment and the application of increased statistical and
methodological rigor over time’’. They concluded that ‘‘the results
indicate that CBT may be effective for the acute treatment of
depression among adolescents, although treatment effects may be
more modest in clinical settings than findings from early trials
would suggest’’ [17].
Null or negative results becoming positive
Cumulative meta-analyses have also shown how replications
have sometimes challenged initially unfavourable results [19–20],
but these examples are fewer and weaker than for the previous
theme. For example, in a systematic review comparing plating
versus intramedullary nailing of humeral shaft fractures in adults,
the cumulative meta-analyses by Li and colleagues showed that
intramedullary nailing might increase the re-operation rate in
studies conducted before 2000 (odds radio (OR): 0.39, 95%
confidence interval (CI): 0.17 to 0.90, P= 0.03). They noted that
although the point estimate was still unfavourable, the difference
was not statistically significant in studies conducted after that year
(OR: 0.54, 95% CI: 0.27 to 1.08, P = 0.08) [19].
Stable results
This collection of cumulative meta-analyses includes many that
show that a systematic review of existing research would have
reduced uncertainty about an intervention. They showed how
morbidity and mortality might have been reduced, both for
patients in general and for participants in trials in which they may
have continued to be allocated to a placebo or a control group
when the intervention could have been shown to be effective in a
meta-analysis [1–2,12–14,18,21–38].This observation also has
implications for waste in research, since new studies might have
been regarded as unjustified if a systematic review and meta-
analysis had been done as part of its design phase. Two examples,
through two decades, are used to illustrate this.
In 1992, Lau and colleagues reported a collection of cumulative
meta-analyses of clinical trials that evaluated 15 treatments and
preventive measures for acute myocardial infarction. They found a
consistent, statistically significant reduction in total mortality for
the use of streptokinase (OR: 0.74, 95% CI: 0.59 to 0.92) would
have been shown in 1973, after only eight trials involving 2432
patients had been completed. The results of 25 subsequent trials,
which enrolled an additional 34,542 patients through 1988, had
little or no effect on the odds ratio establishing efficacy, but
narrowed the 95% confidence interval [1].
The cumulative meta-analysis by Fergusson and colleagues of
aprotinin in cardiac surgery found a dramatically beneficial result
in the first trial of 22 patients in 1987 (OR for perioperative blood
transfusion: 0.03, 95% CI: 0.00 to 0.56), with the point estimate
declining over subsequent randomised trials. By the twelfth study
(published in June 1992), the cumulative effect estimate for the
odds ratio had stabilized (OR: 0.25, P,0.000001) with a total of
approximately 2500 patients randomised. Throughout the cumu-
lative meta-analysis, the upper limit of the confidence interval did
not go higher than 0.65, and in this study, the final meta-analyses
was 0.34 (95% CI: 0.24–0.41) after the publication of a trial in
June 2002, by which time a total of more than 8000 patients had
been randomised [13].
New trials too small to resolve remaining uncertainties
Although systematic reviews of existing evidence sometimes
reveal data that are sufficient to answer research questions,
cumulative meta-analyses, like that of tranexamic acid [39], have
also exposed questions that remain unanswered, but continue to
be addressed in studies that are much too small to resolve the
remaining uncertainties [15,40–56]. The importance of addressing
uncertainties was revealed when a systematic review showed that a
series of 16 under-powered trials conducted over 23 years failed to
indicate whether steroids given to patients with traumatic brain
injury reduced or increased their chances of survival. The
uncertainty was only resolved when a very large trial showed
reliably that the treatment increased mortality [57].
Discussion
This large collection of cumulative meta-analyses, from across
health and social care, and covering a wide range of research into
the effects of interventions, highlights how a review of the existing
evidence might have helped researchers, practitioners, patients
and funders make more informed decisions and choices about new
clinical trials over many decades of research. The importance of
taking account of earlier research is not a new concept for either
the design or interpretation of new studies. For example, it was
highlighted to the British Association for the Advancement of
Science by Lord Rayleigh in the nineteenth century [58–59].
Cumulative Meta-Analyses
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The cumulative meta-analyses that have been considered
together for the first time in this review provide cautionary tales
about how new research might have been designed and
implemented, when the existing research would have shown it to
be unnecessary. Other research, taking a different approach to this
review, has also highlighted this problem. In 2011, Herbison and
colleagues reported cumulative meta-analysis of data from 65
meta-analyses from 18 Cochrane Reviews. They found that it took
a median of four (interquartile range: 1 to 6) studies to get within
10% of the final point estimate. However, they noted that
although their study suggests that, in many cases, only a few trials
are necessary before getting a reasonably robust answer, it is
difficult to know which meta-analyses will change further and
which will not. They conclude ‘‘it is still unclear what character-
istics of early trials will lead to more confidence being placed in the
results of individual meta-analyses’’ [35].
It is also important to recognise how unreliable initial evidence
can be [60–61]. An analysis of data from 85,000 meta-analyses
with binary outcomes in Cochrane Reviews showed that early
trials tend to overestimate treatment effects [62]. This may result,
for example, from studies selecting unrepresentative subgroups of
patients known to have responded favourably to similar interven-
tions previously, or from excluding patients who have not
responded [63]; from biased under-reporting of early trials with
disappointing results [64]; or time-lag bias in the publication of the
results of trials [65]. As a result, early studies and meta-analyses of
them may tend to yield inflated estimates of effects and this needs
to be taken into account in considering proposals for additional
studies [66]. However, an assessment of the existing evidence is
still crucial to providing the ethical, scientific and environmental
justification for proposed new trials. Without such reviews, those
responsible for proposed new trials cannot make a well-informed
decision about whether to proceed with them, and they need to
include careful assessment of the quality and risk of bias in the
studies being brought together [67]. This should influence the
interpretation of the results of the cumulative meta-analysis,
alongside consideration of the possibility that spurious results
might arise due to cumulative testing. This may require the use of
statistical techniques such as sequential analysis, and the need to
consider the statement ‘‘Don’t Ignore Chance Effects’’ when
building from early, positive findings [68].
In considering possible limitations of our research, we note that
systematic reviews of healthcare interventions are subject to the
impact of selective reporting by researchers, in which whole
studies might not be published [69] or, even if studies are
published, particular findings might be excluded because of the
authors’ or editors’ opinions about the findings [70]. This
methodological review could also be subject to such biases, where
cumulative meta-analyses may have been performed but not
reported. In contrast to clinical trials [71] or, more recently,
systematic reviews with health outcomes [72], there is no widely
available system to register prospectively methodological research,
such as cumulative meta-analysis. This makes it impossible to
determine the extent of selective reporting of cumulative meta-
analysis, or its potential impact on our conclusions. Furthermore,
although there were relatively few examples of cumulative meta-
analyses in which benefits appeared for an intervention after the
initial trials had shown null or negative results, this is not
surprising, because awareness of such early results, even without a
formal meta-analysis, might discourage future research. By
contrast, while early positive results might lead to the conduct of
new trials to confirm those results or to test their reproducibility in
other settings [73].
Despite these limitations, however, and given that this review
found such a breadth of examples, it is likely that our general
finding is likely to be valid, namely, that there is a substantial
problem of waste in research resulting from unnecessary duplica-
tion because existing research has not been reviewed before and
after new studies are done [4].
Conclusions
This analysis of 50 reports including over 1500 cumulative
meta-analyses of clinical intervention studies shows that, had
researchers assessed systematically what was already known, some
beneficial and harmful effects of treatments could have been
identified earlier and might have prevented the conduct of the new
trials. This would have led to the earlier uptake of effective health
and social care interventions in practice, less exposure of trial
participants to less effective treatments, and reduced waste
resulting from unjustified research.
We do not argue that the conduct of a new trial in the presence
of apparent certainty from a meta-analysis of existing research is
necessarily wrong in all circumstances. The new trial might serve
to fill a gap or resolve a remaining uncertainty for particular types
of intervention, patient or setting, or seek to assess important
outcomes that were not measured in the earlier trials [74].
However, we do argue that people designing, funding, conducting
and then interpreting new studies should make their decision to do
so in light of an up-to-date systematic review and, if possible, meta-
analysis of existing related research. This would allow them to
show the ethical, scientific and environmental basis for their
proposed new trials, and to demonstrate that they would not be
wasteful and justify their decision [8].
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